India's research output is constrained more by domestic structural factors than by external trade barriers. Critically examine with reference to R&D financing patterns.

India's Gross Expenditure on R&D (GERD) stood at 0.66%, 0.66% and 0.64% of GDP in 2018-19, 2019-20 and 2020-21 respectively — a plateau sustained through years of both buoyant and restricted trade [1][2]. This trajectory suggests that the binding constraint lies in domestic financing structure rather than in external trade barriers.

Financing pattern as the core structural constraint

• Chronic underinvestment: GERD has stagnated near 0.6–0.7% of GDP for over a decade, against the long-standing policy aspiration of a far higher research intensity [2].
• State-dominated funding: in 2020-21, Central Government (43.7%), State Governments (6.7%), higher education (8.8%) and public sector industry (4.4%) drove GERD, with private industry contributing only 36.4% — against over 70% in China, South Korea and the United States [1][2]. Research funding therefore rides on annual budget cycles rather than on a broad-based industrial R&D culture.
• Fragmented architecture: extramural support flows through multiple agencies, with DST (55%) and DBT (13%) alone accounting for most of it, diluting scale and strategic focus [1].

Human capital deficit

• India had roughly 255 researchers per million population (2017), rising only modestly thereafter — a small fraction of Israel or South Korea [4]. Even generous funding cannot be absorbed without researchers.

The case for external factors — and its limits

• Tariffs and technology-control regimes do raise the cost of imported instrumentation and restrict access to frontier technologies, squeezing R&D-intensive exporters.
• Yet these are marginal, cyclical shocks; no trade barrier explains a decade-long plateau in a domestically determined budget choice.

Corrective step: the Anusandhan National Research Foundation Act, 2023 targets ₹50,000 crore over 2023-28, of which ₹14,000 crore is budgetary and the rest is to be mobilised from industry and philanthropy, while subsuming SERB into a single funding body [3].

The evidence thus supports the statement, though external barriers deserve a secondary place rather than dismissal. Sustained public outlays, incentives that deepen private and philanthropic participation, and expansion of the doctoral pipeline can convert ANRF's promise into research output — advancing the constitutional duty under Article 51A(h) to develop the scientific temper.